UVA-1 Phototherapy

DEVICE3 trials

Sponsors

University of Texas Southwestern Medical Center, University of Utah

Conditions

Graft Vs Host DiseaseMorpheaSclerodermaScleroderma, CircumscribedScleroderma, LocalizedScleroderma, Systemic

Unknown Phase

Treatment Study Comparing UVA-1 Phototherapy Versus Placebo Treatment for Morphea

CompletedNCT01799174

University of Texas Southwestern Medical CenterMorphea, Scleroderma, Circumscribed, Scleroderma, Localized

Start: 2012-05-31End: 2019-09-13Updated: 2019-09-25

UVA-1 for Treatment of Skin Tightening and Improvement of Hand Function in Scleroderma

Enrolling by invitationNCT04875078

University of UtahScleroderma

Start: 2020-12-12End: 2025-12-31Target: 30Updated: 2024-12-18

Patient Reported Outcomes With UVA-1 Therapy for Treatment of Sclerosing Skin Diseases

Active, not recruitingNCT04922736

University of UtahGraft Vs Host Disease, Morphea, Scleroderma, Systemic

Start: 2021-06-07End: 2026-06-01Target: 30Updated: 2026-01-23